(Q41750885)

8 October 2017

1 reference

title

Antibiotic use in the critical care unit (English)

1 reference

8 October 2017

0 references

Ambrose PG

1

1 reference

8 October 2017

Owens RC Jr

2

1 reference

8 October 2017

Quintiliani R

3

1 reference

8 October 2017

Yeston N

4

1 reference

8 October 2017

Crowe HM

5

1 reference

8 October 2017

Cunha BA

6

1 reference

8 October 2017

Nightingale CH

7

1 reference

8 October 2017

publication date

1 April 1998

1 reference

8 October 2017

published in

Critical Care Clinics

1 reference

8 October 2017

volume

14

1 reference

8 October 2017

issue

2

1 reference

8 October 2017

page(s)

283-308

1 reference

Consequences of intravascular catheter sepsis

8 October 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0749-0704%2805%2970396-1

7 January 2021

Community-acquired pneumonia

1 reference

https://api.crossref.org/works/10.1016%2FS0749-0704%2805%2970396-1

7 January 2021

Diagnosis and treatment of nosocomial pneumonia in patients in intensive care units

1 reference

https://api.crossref.org/works/10.1016%2FS0749-0704%2805%2970396-1

7 January 2021

Drug fever. The importance of recognition

1 reference

https://api.crossref.org/works/10.1016%2FS0749-0704%2805%2970396-1

7 January 2021

Clinical use of liposomal and lipid-complexed amphotericin B.

1 reference

https://api.crossref.org/works/10.1016%2FS0749-0704%2805%2970396-1

7 January 2021

Clinical manifestations and risk factors of Pseudomonas aeruginosa infection in patients with AIDS.

1 reference

https://api.crossref.org/works/10.1016%2FS0749-0704%2805%2970396-1

7 January 2021

Pharmacodynamics of a fluoroquinolone antimicrobial agent in a neutropenic rat model of Pseudomonas sepsis

1 reference

https://api.crossref.org/works/10.1016%2FS0749-0704%2805%2970396-1

7 January 2021

Pharmacodynamics and pharmacokinetics of antibiotics with special reference to the fluoroquinolones

1 reference

https://api.crossref.org/works/10.1016%2FS0749-0704%2805%2970396-1

7 January 2021

Fungicidal effect of amphotericin B in urine: in vitro study to assess feasibility of bladder washout for localization of site of candiduria

1 reference

https://api.crossref.org/works/10.1016%2FS0749-0704%2805%2970396-1

7 January 2021

Comparison of the bactericidal activities of ofloxacin and ciprofloxacin alone and in combination with ceftazidime and piperacillin against clinical strains of Pseudomonas aeruginosa

1 reference

https://api.crossref.org/works/10.1016%2FS0749-0704%2805%2970396-1

7 January 2021

Pharmacodynamics of intravenous ciprofloxacin in seriously ill patients

1 reference

https://api.crossref.org/works/10.1016%2FS0749-0704%2805%2970396-1

7 January 2021

Once-daily aminoglycoside therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0749-0704%2805%2970396-1

7 January 2021

New approaches in the diagnosis of nosocomial pneumonia.

1 reference

https://api.crossref.org/works/10.1016%2FS0749-0704%2805%2970396-1

7 January 2021

From the Infectious Diseases Society of America. Guidelines for the use of antimicrobial agents in neutropenic patients with unexplained fever

1 reference

https://api.crossref.org/works/10.1016%2FS0749-0704%2805%2970396-1

7 January 2021

Clinical response to aminoglycoside therapy: importance of the ratio of peak concentration to minimal inhibitory concentration

1 reference

https://api.crossref.org/works/10.1016%2FS0749-0704%2805%2970396-1

7 January 2021

The evolution of resistance to cephalosporins

1 reference

https://api.crossref.org/works/10.1016%2FS0749-0704%2805%2970396-1

7 January 2021

Experience with a once-daily aminoglycoside program administered to 2,184 adult patients

1 reference

https://api.crossref.org/works/10.1016%2FS0749-0704%2805%2970396-1

7 January 2021

Choosing between the new cephalosporin antibiotics: a pharmacodynamic approach

1 reference

https://api.crossref.org/works/10.1016%2FS0749-0704%2805%2970396-1

7 January 2021

Bioavailability of fluconazole administered via a feeding tube in intensive care unit patients

1 reference

https://api.crossref.org/works/10.1016%2FS0749-0704%2805%2970396-1

7 January 2021

Bactericidal Activity of Cephalosporins in an In Vitro Model Simulating Serum Levels

1 reference

https://api.crossref.org/works/10.1016%2FS0749-0704%2805%2970396-1

7 January 2021

Infectious complications of indwelling vascular catheters

1 reference

https://api.crossref.org/works/10.1016%2FS0749-0704%2805%2970396-1

7 January 2021

A randomized trial comparing fluconazole with amphotericin B for the treatment of candidemia in patients without neutropenia. Candidemia Study Group and the National Institute

1 reference

https://api.crossref.org/works/10.1016%2FS0749-0704%2805%2970396-1

7 January 2021

Lack of toxicity of long-term, high total dose liposomal amphotericin B

1 reference

https://api.crossref.org/works/10.1016%2FS0749-0704%2805%2970396-1

7 January 2021

Increase inCandida kruseiInfection among Patients with Bone Marrow Transplantation and Neutropenia Treated Prophylactically with Fluconazole

1 reference

https://api.crossref.org/works/10.1016%2FS0749-0704%2805%2970396-1

7 January 2021

Infections in liver transplant recipients

1 reference

https://api.crossref.org/works/10.1016%2FS0749-0704%2805%2970396-1

7 January 2021

10.1016/S0749-0704(05)70396-1

Identifiers

DOI

1 reference

8 October 2017

1 reference